COVID-19 patients on remdesivir had 31% faster recovery — trial shows

Patients who were hospitalized with advanced COVID-19 and breathing problems recovered faster on antiviral drug remdesivir than similar patients on a placebo, according to preliminary data from a large US-led trial.

“Preliminary results indicate that patients who received remdesivir had a 31 percent faster time to recovery than those who received placebo,” says the US National Institute of Allergy and Infectious Diseases in a statement.

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.